123 related articles for article (PubMed ID: 3149649)
1. Migration of tetrahydroisoquinoline, a possible parkinsonian neurotoxin, into monkey brain from blood as proved by gas chromatography-mass spectrometry.
Niwa T; Takeda N; Tatematsu A; Matsuura S; Yoshida M; Nagatsu T
J Chromatogr; 1988 Oct; 452():85-91. PubMed ID: 3149649
[TBL] [Abstract][Full Text] [Related]
2. An endogenous substance of the brain, tetrahydroisoquinoline, produces parkinsonism in primates with decreased dopamine, tyrosine hydroxylase and biopterin in the nigrostriatal regions.
Nagatsu T; Yoshida M
Neurosci Lett; 1988 Apr; 87(1-2):178-82. PubMed ID: 2898112
[TBL] [Abstract][Full Text] [Related]
3. Presence of tetrahydroisoquinoline and 2-methyl-tetrahydroquinoline in parkinsonian and normal human brains.
Niwa T; Takeda N; Kaneda N; Hashizume Y; Nagatsu T
Biochem Biophys Res Commun; 1987 Apr; 144(2):1084-9. PubMed ID: 3579928
[TBL] [Abstract][Full Text] [Related]
4. Metabolism and brain accumulation of tetrahydroisoquinoline (TIQ) a possible parkinsonism inducing substance, in an animal model of a poor debrisoquine metabolizer.
Ohta S; Tachikawa O; Makino Y; Tasaki Y; Hirobe M
Life Sci; 1990; 46(8):599-605. PubMed ID: 2308469
[TBL] [Abstract][Full Text] [Related]
5. Endogenous synthesis of N-methyl-1,2,3,4-tetrahydroisoquinoline, a precursor of N-methylisoquinolinium ion, in the brains of primates with parkinsonism after systemic administration of 1,2,3,4-tetrahydroisoquinoline.
Niwa T; Yoshizumi H; Tatematsu A; Matsuura S; Yoshida M; Kawachi M; Naoi M; Nagatsu T
J Chromatogr; 1990 Nov; 533():145-51. PubMed ID: 2127934
[No Abstract] [Full Text] [Related]
6. Capillary liquid chromatography-tandem mass spectrometry of tetrahydroisoquinoline derived neurotoxins: a study on the blood-brain barrier of rat brain.
Song Y; Xu J; Hamme A; Liu YM
J Chromatogr A; 2006 Jan; 1103(2):229-34. PubMed ID: 16310796
[TBL] [Abstract][Full Text] [Related]
7. Metabolism and penetration through blood-brain barrier of parkinsonism-related compounds. 1,2,3,4-Tetrahydroisoquinoline and 1-methyl-1,2,3,4-tetrahydroisoquinoline.
Kikuchi K; Nagatsu Y; Makino Y; Mashino T; Ohta S; Hirobe M
Drug Metab Dispos; 1991; 19(1):257-62. PubMed ID: 1673411
[TBL] [Abstract][Full Text] [Related]
8. Reduction of 1-methyl 1,2,3,4-tetrahydroisoquinoline level in substantia nigra of the aged rat.
Ayala A; Parrado J; Cano J; Machado A
Brain Res; 1994 Feb; 638(1-2):334-6. PubMed ID: 8199872
[TBL] [Abstract][Full Text] [Related]
9. Parkinsonism produced by tetrahydroisoquinoline (TIQ) or the analogues.
Yoshida M; Ogawa M; Suzuki K; Nagatsu T
Adv Neurol; 1993; 60():207-11. PubMed ID: 8093578
[TBL] [Abstract][Full Text] [Related]
10. Chronic administration of 1-benzyl-1,2,3,4-tetrahydroisoquinoline, an endogenous amine in the brain, induces parkinsonism in a primate.
Kotake Y; Yoshida M; Ogawa M; Tasaki Y; Hirobe M; Ohta S
Neurosci Lett; 1996 Oct; 217(1):69-71. PubMed ID: 8905742
[TBL] [Abstract][Full Text] [Related]
11. Effect of tetrahydroisoquinoline (TIQ), one of endogenous substances inducing parkinsonism, on isolated rat vas deferens.
Koike K; Takayanagi I; Wani S; Yanagita T; Ohta S; Hirobe M
Gen Pharmacol; 1989; 20(2):259-60. PubMed ID: 2714622
[TBL] [Abstract][Full Text] [Related]
12. Interaction of 1,2,3,4-tetrahydroisoquinoline with some components of cigarette smoke: potential implications for Parkinson's Disease.
Soto-Otero R; Riguera-Vega R; Méndez-Alvarez E; Sánchez-Sellero I; López-Rivadulla Lamas M
Biochem Biophys Res Commun; 1996 May; 222(2):607-11. PubMed ID: 8670252
[TBL] [Abstract][Full Text] [Related]
13. [Tetrahydroisoquinolines in connection with Parkinson's disease].
Ohta S
Rinsho Shinkeigaku; 1989 Dec; 29(12):1504-6. PubMed ID: 2698297
[TBL] [Abstract][Full Text] [Related]
14. Detection of tetrahydroisoquinoline in parkinsonian brain as an endogenous amine by use of gas chromatography-mass spectrometry.
Niwa T; Takeda N; Sasaoka T; Kaneda N; Hashizume Y; Yoshizumi H; Tatematsu A; Nagatsu T
J Chromatogr; 1989 Jul; 491(2):397-403. PubMed ID: 2808624
[No Abstract] [Full Text] [Related]
15. Presence of 2-methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline and 1,2-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, novel endogenous amines, in parkinsonian and normal human brains.
Niwa T; Takeda N; Yoshizumi H; Tatematsu A; Yoshida M; Dostert P; Naoi M; Nagatsu T
Biochem Biophys Res Commun; 1991 Jun; 177(2):603-9. PubMed ID: 2049084
[TBL] [Abstract][Full Text] [Related]
16. Detection of 1-phenyl-N-methyl-1,2,3,4-tetrahydroisoquinoline and 1-phenyl-1,2,3,4-tetrahydroisoquinoline in human brain by gas chromatography-tandem mass spectrometry.
Kajita M; Niwa T; Fujisaki M; Ueki M; Niimura K; Sato M; Egami K; Naoi M; Yoshida M; Nagatsu T
J Chromatogr B Biomed Appl; 1995 Jul; 669(2):345-51. PubMed ID: 7581910
[TBL] [Abstract][Full Text] [Related]
17. Parkinsonism in monkeys produced by chronic administration of an endogenous substance of the brain, tetrahydroisoquinoline: the behavioral and biochemical changes.
Yoshida M; Niwa T; Nagatsu T
Neurosci Lett; 1990 Oct; 119(1):109-13. PubMed ID: 1982957
[TBL] [Abstract][Full Text] [Related]
18. Presence of tetrahydroisoquinoline and 1-methyl-tetrahydro-isoquinoline in foods: compounds related to Parkinson's disease.
Makino Y; Ohta S; Tachikawa O; Hirobe M
Life Sci; 1988; 43(4):373-8. PubMed ID: 3398705
[TBL] [Abstract][Full Text] [Related]
19. Reduction of rat brain levels of the endogenous dopaminergic proneurotoxins 1,2,3,4-tetrahydroisoquinoline and 1,2,3,4-tetrahydro-beta-carboline by cigarette smoke.
Soto-Otero R; Méndez-Alvarez E; Sánchez-Sellero I; Cruz-Landeira A; López-Rivadulla Lamas M
Neurosci Lett; 2001 Feb; 298(3):187-90. PubMed ID: 11165438
[TBL] [Abstract][Full Text] [Related]
20. 1-Benzyl-1,2,3,4-tetrahydroisoquinoline as a parkinsonism-inducing agent: a novel endogenous amine in mouse brain and parkinsonian CSF.
Kotake Y; Tasaki Y; Makino Y; Ohta S; Hirobe M
J Neurochem; 1995 Dec; 65(6):2633-8. PubMed ID: 7595560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
